Overview

Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect and assess information on safety and efficacy of fondaparinux in patients undergoing general surgery of the lower limb at high risk of developing venous thromboembolism.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fondaparinux
PENTA